It is shown that sEH inhibitor treatment significantly lowered left ventricular peak pressure in chronic HF (CHF) animals, which finally remarkably increased survival rate from 14 to 41% (Cervenka et al., 2015a). The gene discussed is EPHX2; the disease is congestive heart failure.